Celcuity Inc. (CELC) vs Regencell Bioscience Holdings Limited (RGC)
A side-by-side comparison of Celcuity Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELC
Celcuity Inc.
$71.63HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
RGC
Regencell Bioscience Holdings Limited
$7.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CELC vs RGC
growth of $100 · dividends reinvested · last 5yCELC +229.0% (+26.9%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
CELC RGC
CELC vs RGC: by the numbers
- •RGC is the larger company ($3.64B vs $3.49B market cap).
Metrics side by side
Valuation
| Metric | CELC | RGC |
|---|---|---|
| P/B ratio | N/A | 2982.47 |
Profitability
| Metric | CELC | RGC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -73.75% |
| ROIC | -28.15% | -69.75% |
Growth (annualized)
| Metric | CELC | RGC |
|---|---|---|
| Total return CAGR (5Y) | 34.40% | 67.94% |
Frequently asked
- How have CELC and RGC total returns compared?
- Over the past 5 years, CELC delivered 34.40% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.